Predicted Trait | |
Reported Trait | Prostate cancer |
Mapped Trait(s) | prostate carcinoma (EFO_0001663) |
Score Construction | |
PGS Name | ldpred2.auto.GCST006085.Prostate_cancer |
Development Method | |
Name | LDpred2-auto |
Parameters | auto |
Variants | |
Original Genome Build | GRCh38 |
Number of Variants | 1,045,276 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000517 |
Citation (link to publication) | Monti R et al. Am J Hum Genet (2024) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST006085 Europe PMC: 29892016 |
140,254 individuals | European | NR |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | 9,671 individuals, 100.0 % Male samples |
European | UKB | — | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM019545 | PSS011221| European Ancestry| 68,516 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.82561 [1.74872905, 1.90587328] β: 0.60191 [0.55888927, 0.64494032] |
AUROC: 0.66494 [0.65364949, 0.67623003] | R²: 0.08081 [0.07028398, 0.09106408] | 0 | beta = log(or)/sd_pgs |
PPM019546 | PSS011232| European Ancestry| 171,474 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.07696 [2.03866736, 2.11597128] β: 0.73091 [0.71229634, 0.74951394] |
AUROC: 0.69616 [0.69165306, 0.70066719] | R²: 0.11538 [0.11020074, 0.12097632] | 0 | beta = log(or)/sd_pgs |
PPM019547 | PSS011245| South Asian Ancestry| 19,738 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.12005 [1.73909535, 2.58444454] β: 0.75144 [0.55336506, 0.94951061] |
AUROC: 0.70701 [0.65372607, 0.76030223] | R²: 0.08588 [0.04466036, 0.13831751] | 0 | beta = log(or)/sd_pgs |
PPM019548 | PSS011261| European Ancestry| 31,410 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 1.93632 [1.85068513, 2.0259163] β: 0.66079 [0.61555591, 0.70602209] |
AUROC: 0.67844 [0.66710517, 0.68977315] | R²: 0.09414 [0.08297157, 0.10691432] | 0 | beta = log(or)/sd_pgs |
PPM019549 | PSS011289| South Asian Ancestry| 4,976 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.34953 [1.93904652, 2.84689917] β: 0.85421 [0.66219637, 1.04623039] |
AUROC: 0.72497 [0.67810544, 0.77184412] | R²: 0.10858 [0.06368116, 0.1638136] | 0 | beta = log(or)/sd_pgs |
PPM019550 | PSS011274| European Ancestry| 41,305 individuals |
PGP000517 | Monti R et al. Am J Hum Genet (2024) |
Reported Trait: Prostate cancer | OR: 2.03998 [1.95464119, 2.1290527] β: 0.71294 [0.67020664, 0.75567714] |
AUROC: 0.69081 [0.68023489, 0.70138671] | R²: 0.11235 [0.100658, 0.12536432] | 0 | beta = log(or)/sd_pgs |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS011274 | — | — | [ ,
100.0 % Male samples |
— | European | — | UKB | — |
PSS011245 | — | — | [ ,
100.0 % Male samples |
— | South Asian | — | G&H | — |
PSS011221 | — | — | [ ,
100.0 % Male samples |
— | European | — | EB | — |
PSS011289 | — | — | [ ,
100.0 % Male samples |
— | South Asian | — | UKB | — |
PSS011261 | — | — | [ ,
100.0 % Male samples |
— | European | — | HUNT | — |
PSS011232 | C3_PROSTATE, ICD10: C61, ICD9: 185 | — | [ ,
100.0 % Male samples |
— | European | — | FinnGen | — |